This was the stock's second consecutive day of losses.

The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...

Investors in Vertex Pharmaceuticals Incorporated VRTX need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2025 $145 Call had some of the ...

NEW YORK, NY / ACCESSWIRE / December 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...

Read about how Crispr's robust pipeline for cardiovascular diseases holds blockbuster potential, with top-line results ...

INR:7810. rummy film download Analysis of the success rate of global new drug research and development Vertex's three therapies have been accepted by the US F ...

The medicine hit its primary endpoint of a decrease in the average daily leg pain intensity as measured by the Numeric Pain ...

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

Of the top news articles, Vertex Pharmaceuticals' suzetrigine garnered much attention as it's a promising new class of pain ...

INR:5823. draftkings slots Bayer's FX1a inhibitor for stroke prevention receives two clinical trials in China Vertex's innovative triple therapy Kaftrio is about ...

Despite the real problems with the additional indication being sought for suzetrigine, this drop in the stock is still an ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Oruka Therapeutics (ORKA – Research Report), ...